Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0187 Transporter Info
Gene Name	SLC25A26
Transporter Name	S-adenosylmethionine mitochondrial carrier protein
Gene ID	115286
UniProt ID	Q70HW3

Post-Translational Modification of This DT
Overview of SLC25A26 Modification Sites with Functional and Structural Information
Sequence	M D R P G F V A A L V A G G V A G V S V D L I L F P L D T I K T R L Q S P Q G F S K A G G F H G I Y A G V P S A A I G S F P N A A A F F I T Y E Y V K W F L H A D S S S Y L T P M K H M L A A S A G E V V A C L I R V P S E V V K Q R A Q V S A S T R T F Q I F S N I L Y E E G I Q G L Y R G Y K S T V L R E I P F S L V Q F P L W E S L K A L W S W R Q D H V V D S W Q S A V C G A F A G G F A A A V T T P L D V A K T R I T L A K A G S S T A D G N V L S V L H G V W R S Q G L A G L F A G V F P R M A A I S L G G F I F L G A Y D R T H S L L L E V G R K S P
PTM type	X-Phosphorylation X-Ubiquitination X: Amino Acid

Phosphorylation
Serine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A26			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	129
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A26 Serine 129 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC25A26			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	264
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A26 Serine 264 has the potential to affect its expression or activity.
Threonine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A26			[1]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	124
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A26 Threonine 124 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC25A26			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	147
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A26 Threonine 147 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC25A26			[2] , [4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	262
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A26 Threonine 262 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A26			[1]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	133
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A26 Tyrosine 133 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC25A26			[1]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	141
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A26 Tyrosine 141 has the potential to affect its expression or activity.
Ubiquitination
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A26			[5]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	113
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A26 Lysine 113 has the potential to affect its expression or activity.

References
1	Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. Oncotarget. 2016 Nov 15;7(46):75968-75980.
2	Identification of novel signaling components in genistein-regulated signaling pathways by quantitative phosphoproteomics. J Proteomics. 2011 Dec 21;75(2):695-707.
3	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
4	Protein kinase PKN1 represses Wnt/beta-catenin signaling in human melanoma cells. J Biol Chem. 2013 Nov 29;288(48):34658-70.
5	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence